HRP20010277B1 - Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative - Google Patents

Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative

Info

Publication number
HRP20010277B1
HRP20010277B1 HR20010277A HRP20010277A HRP20010277B1 HR P20010277 B1 HRP20010277 B1 HR P20010277B1 HR 20010277 A HR20010277 A HR 20010277A HR P20010277 A HRP20010277 A HR P20010277A HR P20010277 B1 HRP20010277 B1 HR P20010277B1
Authority
HR
Croatia
Prior art keywords
nitecapone
entacapone
cellulose derivative
well
cross
Prior art date
Application number
HR20010277A
Other languages
English (en)
Croatian (hr)
Inventor
Vahervuo Kari
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22542186&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20010277(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of HRP20010277A2 publication Critical patent/HRP20010277A2/hr
Publication of HRP20010277B1 publication Critical patent/HRP20010277B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
HR20010277A 1998-09-14 2001-04-12 Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative HRP20010277B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/152,263 US6599530B2 (en) 1998-09-14 1998-09-14 Oral compacted composition comprising catechol derivatives
PCT/FI1999/000740 WO2000015196A1 (en) 1998-09-14 1999-09-13 Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative

Publications (2)

Publication Number Publication Date
HRP20010277A2 HRP20010277A2 (en) 2002-06-30
HRP20010277B1 true HRP20010277B1 (en) 2010-10-31

Family

ID=22542186

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20010277A HRP20010277B1 (en) 1998-09-14 2001-04-12 Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative

Country Status (39)

Country Link
US (1) US6599530B2 (xx)
EP (1) EP1112065B1 (xx)
JP (1) JP4619537B2 (xx)
KR (1) KR100732187B1 (xx)
CN (1) CN1151778C (xx)
AR (1) AR021806A1 (xx)
AT (1) ATE256454T1 (xx)
AU (1) AU746889B2 (xx)
BG (1) BG65041B1 (xx)
BR (1) BR9913681A (xx)
CA (1) CA2342634C (xx)
CO (1) CO5130008A1 (xx)
CZ (1) CZ293960B6 (xx)
DE (1) DE69913714T2 (xx)
DK (1) DK1112065T3 (xx)
EA (1) EA003282B1 (xx)
EE (1) EE04657B1 (xx)
ES (1) ES2213381T3 (xx)
GE (1) GEP20033062B (xx)
HK (1) HK1039750B (xx)
HR (1) HRP20010277B1 (xx)
HU (1) HU228910B1 (xx)
ID (1) ID29026A (xx)
IL (1) IL141681A0 (xx)
ME (1) ME00706B (xx)
MY (1) MY124394A (xx)
NO (1) NO331641B1 (xx)
NZ (1) NZ510583A (xx)
PE (1) PE20001060A1 (xx)
PL (1) PL193454B1 (xx)
PT (1) PT1112065E (xx)
RS (1) RS49723B (xx)
SI (1) SI1112065T1 (xx)
SK (1) SK284049B6 (xx)
TR (1) TR200100752T2 (xx)
TW (1) TWI222367B (xx)
UA (1) UA73925C2 (xx)
WO (1) WO2000015196A1 (xx)
ZA (1) ZA200102084B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI109453B (fi) 1999-06-30 2002-08-15 Orion Yhtymae Oyj Farmaseuttinen koostumus
FI20000635A0 (fi) * 2000-03-17 2000-03-17 Orion Yhtymae Oyj COMT-inhibiittoreiden käyttö analgeettina
US7659253B2 (en) * 2002-02-22 2010-02-09 Shire Llc Abuse-resistant amphetamine prodrugs
JP2008519811A (ja) 2004-11-10 2008-06-12 オリオン コーポレーション 下肢静止不能症候群の治療
AU2012216377C1 (en) * 2005-06-08 2013-10-10 Orion Corporation Oral dosage form
EA013161B1 (ru) * 2005-06-08 2010-02-26 Орион Корпорейшн Дозированная форма для перорального применения
WO2007069274A2 (en) * 2005-11-09 2007-06-21 Torrent Pharmaceuticals Limited Pharmaceutical composition comprising a compound having a catechol moiety and an alkalising agent
CA2642761A1 (en) * 2006-02-23 2007-08-30 Iomedix Sleep International Srl Compositions and methods for the induction and maintenance of quality sleep
GB2429645A (en) * 2006-03-10 2007-03-07 Sekhsaria Chemicals Ltd Solid pharmaceutical composition comprising a COMT inhibitor, a starch and a wetting agent
WO2007113371A1 (en) * 2006-03-31 2007-10-11 Iprbox Oy Pharmaceutical composition and preparation method thereof
CA2572004A1 (en) * 2006-12-08 2008-06-08 Bernard Charles Sherman Tablets comprising entacapone and crospovidone
EP1946756A1 (en) * 2007-01-17 2008-07-23 Revotar Biopharmaceuticals AG Use of entacapone in cosmetic, dermatological and pharmaceutical compositions
RU2010136934A (ru) * 2008-02-06 2012-03-20 Вокхард Рисерч Сентер (In) Фармацевтические композиции энтакапона, микронизированного с сахарными спиртами
JP5466179B2 (ja) * 2008-02-06 2014-04-09 ウォックハート リサーチ センター 生物学的利用能が改善されたエンタカポン、レボドパ及びカルビドパの医薬組成物
NZ591326A (en) * 2008-08-22 2012-12-21 Wockhardt Research Center An extended release pharmaceutical composition of entacapone or salts thereof
JP5718937B2 (ja) * 2009-12-25 2015-05-13 イノファーマックス インコーポレイテッド パーキンソン病を治療するための医薬組成物及びその調製方法
WO2012147099A1 (en) 2011-04-25 2012-11-01 Suven Nishtaa Pharma Pvt. Ltd. Pharmaceutical compositions of levodopa, carbidopa and entacapone
EP2702991A4 (en) * 2011-04-26 2015-02-18 Innopharmax Inc COMPOSITION OF ENTACOPONE
WO2016083863A1 (en) 2014-11-28 2016-06-02 Bial - Portela & Ca, S.A. Medicaments for slowing parkinson's disease
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
EP3275433A1 (en) * 2016-07-29 2018-01-31 Som Innovation Biotech S.L. Sustained release composition comprising micronized tolcapone
CN106236720A (zh) * 2016-08-29 2016-12-21 海南通用康力制药有限公司 一种恩他卡朋的药物组合物及其制备方法
CN113274362A (zh) * 2021-03-31 2021-08-20 海南通用康力制药有限公司 恩他卡朋片的生产方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446194A (en) * 1986-11-28 1995-08-29 Orion-Yhtyma Oy Pharmacologically active catechol derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0301006B1 (en) * 1986-04-01 1992-05-06 The Upjohn Company Methylprednisolone/sodium carboxymethyl starch tablet composition
YU213587A (en) * 1986-11-28 1989-06-30 Orion Yhtymae Oy Process for obtaining new pharmacologic active cateholic derivatives
US5489614A (en) * 1987-11-27 1996-02-06 Orion-Yhtyma Oy Catechol derivatives, their physiologically acceptable salts, esters and use
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
TW430561B (en) * 1995-12-20 2001-04-21 Gea Farmaceutisk Fabrik As Rapid release tablet composition comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tablet

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446194A (en) * 1986-11-28 1995-08-29 Orion-Yhtyma Oy Pharmacologically active catechol derivatives

Also Published As

Publication number Publication date
BR9913681A (pt) 2001-06-05
RS49723B (sr) 2007-12-31
JP2002524493A (ja) 2002-08-06
ATE256454T1 (de) 2004-01-15
SK284049B6 (sk) 2004-08-03
ID29026A (id) 2001-07-26
BG65041B1 (bg) 2007-01-31
HK1039750B (zh) 2005-02-18
NZ510583A (en) 2002-09-27
EA003282B1 (ru) 2003-04-24
HU228910B1 (en) 2013-06-28
SI1112065T1 (en) 2004-04-30
IL141681A0 (en) 2002-03-10
CN1319005A (zh) 2001-10-24
CZ2001792A3 (cs) 2001-08-15
US20020132009A1 (en) 2002-09-19
TR200100752T2 (tr) 2001-10-22
CZ293960B6 (cs) 2004-08-18
DE69913714T2 (de) 2004-10-07
TWI222367B (en) 2004-10-21
ZA200102084B (en) 2002-06-13
PL346618A1 (en) 2002-02-25
KR20010075084A (ko) 2001-08-09
WO2000015196A1 (en) 2000-03-23
UA73925C2 (uk) 2005-10-17
ME00706B (me) 2007-12-31
YU19301A (sh) 2003-02-28
EE04657B1 (et) 2006-08-15
EE200100147A (et) 2002-06-17
DK1112065T3 (da) 2004-04-05
KR100732187B1 (ko) 2007-06-27
HUP0103454A2 (hu) 2002-01-28
SK3072001A3 (en) 2002-05-09
AU5748299A (en) 2000-04-03
US6599530B2 (en) 2003-07-29
NO20011278D0 (no) 2001-03-13
EP1112065A1 (en) 2001-07-04
NO331641B1 (no) 2012-02-13
EP1112065B1 (en) 2003-12-17
CA2342634C (en) 2008-01-29
CA2342634A1 (en) 2000-03-23
AU746889B2 (en) 2002-05-02
JP4619537B2 (ja) 2011-01-26
CO5130008A1 (es) 2002-02-27
PT1112065E (pt) 2004-04-30
PE20001060A1 (es) 2000-10-20
HK1039750A1 (en) 2002-05-10
GEP20033062B (en) 2003-09-25
DE69913714D1 (de) 2004-01-29
ES2213381T3 (es) 2004-08-16
CN1151778C (zh) 2004-06-02
AR021806A1 (es) 2002-08-07
BG105436A (en) 2001-11-30
MY124394A (en) 2006-06-30
EA200100354A1 (ru) 2001-08-27
PL193454B1 (pl) 2007-02-28
HUP0103454A3 (en) 2003-11-28
HRP20010277A2 (en) 2002-06-30
NO20011278L (no) 2001-03-13

Similar Documents

Publication Publication Date Title
HRP20010277B1 (en) Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative
BR9710372B1 (pt) composto, e, composiÇço farmacÊutica.
IS4963A (is) Setnar 6,5-heteró-bísýklískar afleiður
BR9804500B1 (pt) derivado de amida, referida composição farmacêutica e agente terapêutico.
IS4565A (is) 2-methýl-thíenó-bensódíasepín, samsetning til inntöku
TR199700049A2 (tr) Düsük CO'lu sigara.
PT1112266E (pt) 4-amino-2-aril-pirimidinas substituidas, sua preparacao, sua utilizacao e composicoes farmaceuticas que as contem.
IT1290383B1 (it) Compressore perfezionato per refrigeranti.
PT1159960E (pt) Composicoes farmaceuticas baseadas em diclofenac
RS49772B (sr) Farmaceutske kompozicije
TR199501082A2 (tr) Farmasötik formülasyonlar.
BRPI9703099B8 (pt) derivado de carboidrato, e, composição farmacêutica
HRP20000703B1 (en) Stabile compositions levosimendan and alginic acid
MA26604A1 (fr) Compositions pharmaceutiques.
DE69636837D1 (de) 1,2,4-benzotriazinoxid-formulierungen
TR199700219A3 (tr) 1,25-Dihidroksi-16, 22, 23-Trisdihidro-kolkalsiferol türevleri.
ES1035932Y (es) Adimento para implantes perfeccionado.
IT1290384B1 (it) Compressore perfezionato per refrigeranti.
ZA974422B (en) Substituted-amidinobenzene derivative and pharmaceutical compositions thereof.
DK1190718T3 (da) Oftalmiske sammensætninger, der omfatter aminoalkoholer
ES1035575Y (es) Calzado perfeccionado.
TR199500776A2 (tr) Farmasötik bilesimler.
ES1031232Y (es) Compresa quirurgica perfeccionada.
FI972988A0 (fi) Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä
HK1070895A1 (en) Pharmaceutical compositions comprising 2,3 -diarylpyrazolo Ä1,5.bÜpyridazine derivatives

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20180910

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20190913